Home / People / Noah Rodenkirchen
Portrait ofNoah Rodenkirchen

Noah Rodenkirchen, LL.M. University of Aberdeen

Associate
Rechtsanwalt

CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
Germany
Languages German, English

Noah Rodenkirchen specialises in the life sciences and healthcare sector, with a focus on advising on the digitalisation of the healthcare sector and regulatory issues, drafting contracts and advising on transactions. He has expert know-how in pharmaceutical law, medical device law, the law on advertising in the health sector, public health law and product liability law.

Noah joined CMS in 2023.

more less

Memberships & Roles

  • German-Swiss Lawyers‘ Association
more less

Education

  • 2021 - 2023: Trainee lawyer in Karlsruhe Higher Regional Court district including placements at a boutique law firm specialising in healthcare & life sciences law and corporate law firms in Berlin and Zurich
  • 2020 - 2021: LL.M. in Intellectual Property Law at the University of Aberdeen, Scotland
  • 2014 - 2019: Law studies at the University of Konstanz
more less

Feed

08/08/2024
CMS advises US company Bruker on acquisition of strategic minority stake...
Frankfurt/Main – Nasdaq-listed Bruker Corporation has announced a strategic investment in NovAliX, a preclinical Contract Research Organisation (CRO) specialising in drug discovery services that is headquartered in Strasbourg, France. The NovAliX Group has subsidiaries in countries including France, Belgium, Spain, the US, Tunisia and Japan. Bruker’s aim in making this investment is to accelerate the growth and further expansion of NovAliX, particularly within Europe and the United States. Bruker and NovAliX intend to collaborate on developing new paradigms in drug discovery by leveraging advanced biophysical methods, particularly NMR, for structural, binding and functional char­ac­ter­isa­tion. The transaction is a milestone in Bruker’s strategy of expanding its position as a partner for high-quality services in the life sciences field. An international CMS team headed by partner Dr Hendrik Hirsch and counsel Dr Berrit Roth-Mingram advised Bruker on all legal aspects of the transaction. Bruker is a longstanding CMS client. The US company regularly relies on the expertise of CMS when making acquisitions and disposals. The current instruction demonstrates once again the successful international collaboration of the CMS offices. In this case, CMS offices in France, Belgium and Spain were involved. Most recently, a large international team led by CMS partner Dr Hendrik Hirsch advised Bruker on its acquisition of the ELITech Group. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Berrit Roth-Mingram, Counsel, Co-Lead Martina Meier-Grom, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Thomas Hirse, Partner Dr Roland Wiring, Partner Thomas Fröhlich, Counsel Dr Siham Hidar, Senior Associate Lisa Dietrich, Associate Noah Rodenkirchen, Associate, all IP Dr Michael Bauer, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Till Komma, Counsel, Banking, Finance & Insurance  CMS France Benoît Gomel, Part­ner François Bossé-Cohic, Counsel Caroline Buyse, Counsel Dylan Allali, As­so­ci­ate Vin­cent Desbenoit, As­so­ci­ate Ant­oine Melchior, Associate, all Corporate/M&A Alexandre Chazot, Counsel Alexis Imbert, both Banking & Finance Arnaud Valverde, Senior As­so­ci­ate Al­izée Fabre-Betti, Associate, both Real Es­tate Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, As­so­ci­ate Solenne Mignot, Lawyer, all IP Caroline Froger-Michon, Partner Florence Duprat-Cerri, Counsel Camille Baumgarten, Associate Sophie Yin, Lawyer, all Em­ploy­ment Claire Vannini, Part­ner Lilia-Ori­ana Dif, As­so­ci­ate Guil­laume Melot, Associate, all Com­pet­i­tion Myri­am El Andaloussi, Associate Paul Letartre, Associate, both TMC Olivier Kuhn, Partner, Dispute Resolution  CMS Belgium Stéphane Collin, Partner Arnaud Van Oekel, Partner Candice Kunkera, Senior Associate Lola Verelst, Associate, all Corporate/M&A Gaël Chuffart, Partner Fatma Ezzahra Sassi, Associate, both Employment Bruno Fonteyn, Senior Associate, Public  CMS Spain Elena Alcázar Cuartero, Coun­sel Ale­jandra Martín Benítez, Associate, both Corporate/M&A Anna De las Cuevas, As­so­ci­ate Guillermo García Diéguez, As­so­ci­ate Fran­cisco Javier Fernández Ródriguez, Lawyer, all Employment Ana Doval Escribá de Romaní, Associate, Public Sol Cruz-Conde de la Moneda, Lawyer, Banking & FinancePress Con­tact presse@cms-hs. com
02/07/2024
CMS advises listed U.S. provider of fertility and women’s health benefits...
Frankfurt/Main, 02.07.2024 – Progyny, Inc., a leading US-based, Nasdaq listed company specializing in women’s health, fertility, and family building benefits, has acquired all shares of Apryl GmbH. Apryl GmbH is a Berlin-based fertility benefits provider founded in 2019 that offers companies a consulting and mediation platform in the areas of family planning, fertility, and reproductive health for their employees in a B2B context. With this acquisition, Progyny aims to enhance its operations in the global market. The parties involved have agreed to keep the transaction details confidential.A CMS team led by Dr Heike Wagner advised Progyny on all legal aspects in connection with this transaction. Press Con­tact presse@cms-hs. com
14/06/2024
CMS advises a consortium of Swiss Life and Vesper on the acquisition of...
Duesseldorf – An international and mul­tidiscip­lin­ary CMS team has advised a consortium of Swiss Life Asset Managers, on behalf of their infrastructure funds, and Vesper Next Generation Infrastructure Fund I SCSp on the acquisition of all shares in RAD-x SAS, a leading Pan-European diagnostic imaging platform, from private equity investor Gilde Healthcare. RAD-x is one of the leading diagnostic imaging providers in Germany and Switzerland. Through its continued focus on technology and innovation, RAD-x remains at the forefront of diagnostic imaging as it provides high quality and reliable diagnostic services to its patients. Established in 2011, the Swiss Life Asset Managers Infrastructure Equity platform manages over EUR 10bn in Assets under Management for its clients and partners, and includes 75 infrastructure investments across the energy, communications, transportation, regulated utilities, social infrastructure and renewable energy sectors. Vesper Infrastructure Partners’ Next Generation Infrastructure Fund I is a closed-end alternative investment fund based in Luxembourg managed by Sanne LIS, which pursues infrastructure investment opportunities, including healthy living solutions. CMS Germany Dr Sebastian Becker, Partner Ole Gunnar Weyand, Senior Associate Nina Becker, As­so­ci­ate Car­oline Rolf, Associate Greta Ludewig, Associate, all Private Equity/M&A Dr Martin Friedberg, Partner Dr Hendrik Arendt, Senior Associate, both Tax Dr Angela Emmert, Partner Lennard Lürwer, Counsel Daniel Hennig, Counsel Dr Mario Brungs, Counsel Dr Yannick Schmitter, Associate, all Employment Law Dr Andreas Hofelich, Partner, Pensions Dr André Frischemeier, Partner Thomas Schaak, Senior Associate Dr Dirk Schmidbauer, Associate, all Finance Kai Neuhaus, Partner Dr Björn Herbers, Partner Moritz Pottek, Counsel David Rappenglück, Associate, all Antitrust and Foreign Investment Control Dr Roland Wiring, Partner Philippe Heinzke, Partner Dr Siham Hidar, Senior As­so­ci­ate Se­basti­an Vautz, Senior Associate Noah Rodenkirchen, Associate, all IP Maike Füchtmann, Senior Associate, Real Estate & Public CMS UK Narinder Jugpal, Partner Ben Mc­Par­land Jen­nifer Ross, all Private Equity/M&A Patrick Donegan, Partner Andreas Göller, both Finance CMS France Thomas Hains, Part­ner Anne-Flore Millet Louise Paysant CMS Switzerland Stephan Werlen, Part­ner Ferdin­and BlezingerPress Con­tact presse@cms-hs. com
28/02/2024
CMS advises Bruker on the multi-jur­is­dic­tion­al acquisition of ELITech,...
Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands. ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases. ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Jacob Siebert, Partner, Co-Lead Dr Dirk Baukholt, Principal Counsel Dr Berrit Roth-Mingram, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Roland Wiring, Partner Lukas Burgdorff, Associate Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Dr Michael Bauer, Partner Stefan Lehr, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel Dr. Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Dr Thomas de la Motte, Partner Dr Markus Pfaff, Partner Dr André Frischemeier, Partner Hatice Aykel, Counsel Alisa Brehm, Senior Associate Thomas Schaak, Senior Associate Dr Sait Dogan, Associate, all Banking & Finance  Dr André Lippert, Part­ner Con­stan­ze Schweidtmann, Associate, both Real Estate & Public Dr Boris Alles, Partner Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions CMS France Benoît Gomel, Partner Vincent Desbenoit, Associate Dylan Allali, all Corporate/M&A Caroline Froger-Michon, Partner Aurélie Parchet, As­so­ci­ate Ca­m­ille Baumgarten, Associate Sophie Yin, all Em­ploy­ment Claire Vannini, Partner Eleni Moraïtou, Coun­sel Lilia-Ori­ana Dif, Associate Ariane Rolin, all Competition & EU  Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, Associate, both Intellectual Property Laurine Mayer, Associate, TMC Alexandre Chazot, Counsel, Banking & Fin­ance  Thi­erry Granier, Partner Renaud Grob, Partner, both Tax Arnaud Valverde, Senior Associate, Real Estate Olivier Kuhn, Partner Cécile Rebiffé, Counsel Mylène Garrouste, all Dispute Res­ol­u­tion Kawthar Ben Khelil, Coun­sel Jean-Pierre Malili, Associate, both Public law/In­fra­struc­ture CMS Italy Massimo Trentino, Partner, Corporate/M&A Maria Letizia Patania, Partner, Lifescience & Healthcare Gian Marco Lettieri, Senior Associate, Employment & Pensions Giulio Poggioli, Counsel Valerio Giuseppe Daniele, As­so­ci­ate Francesca Durante, Junior As­so­ci­ate  Arianna Toccaceli, Junior Associate, all Banking & Finance CMS Luxembourg Gérard Maitrejean, Partner Miruna Poenaru, Coun­sel Max­imili­an Helfgen, Associate, all Corporate/M&A CMS UK Jack Letson, Partner Lindsay McAllister, Associate, both Corporate/M&A David Dennis, Partner, Commercial CMS Netherlands Pieter van Duijvenvoorde, Partner Robert Jong, both Corporate/M&A Nigel Henssen Fleur van Assendelft de Coningh, both Employment Edmon Oude Elferink, Partner Marijke van der Vossen, both Antitrust, Competition & Trade CMS Serbia Radivoje Petrikić, Partner Mila Drljević, both Corporate/M&A CMS Austria Dieter Zandler, Partner Vanessa Horaceck, both Competition & EU CMS Ukraine Maria Orlyk, Partner Diana Valyeyeva CMS Turkiye Döne Yalçın, Partner Arcan Kemahlı,  Sa­ba­hat­tin Öztemiz Taner ElmasPress Con­tact presse@cms-hs. com
16/01/2024
CMS advises listed mobility solutions specialist Össur on acquisition of...
Frankfurt/Main – Össur, Nasdaq Copenhagen listed leading global provider of innovative mobility solutions, acquired all shares of privately owned Fior & Gentz, a Germany based leading European manufacturer of lower limb neuro orthotic components. Fior & Gentz develops and distributes knee and ankle orthotic joints to create innovative custom-made orthotic solutions for patients with gait impairments due to neurological conditions. The acquisition of Fior & Gentz represents an attractive opportunity for Össur to enter the fast-growing neuro orthotics market. The transaction volume amounts to around EUR 100 million plus an earn-out of up to EUR 20 million. The payment consists of cash as well as of newly issued, listed shares of Icelandic Össur hf. to the sellers of Fior & Gentz. An international CMS team led by Dr Heike Wagner and Dr Tobias Kilian advised Össur comprehensively on all legal aspects also in connection with this transaction. CMS Germany Dr Heike Wagner, Partner Dr Tobias Kilian, Of Counsel, both Lead Dr Reiner Thieme, As­so­ci­ate Nath­alie Amrhen, Associate, all Corporate / M&A Jörg Schrade, Partner Eduard Kosavtsev, Senior Associate, both Tax Dr Roland Wiring, Partner Dr Siham Hidar, Senior Associate  Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Stefan Lehr, Partner, Antitrust, Competition & Trade Dr Dirk Smielick, Principal Counsel, IP Prof Dr Malte Grützmacher, Partner, IT Dr Boris Alles, Partner Dela Herr, Associate, both Labor, Employment & Pensions  Dr Franz Maurer, Counsel Wiebke Westermann, Associate, both Real Estate & Public CMS Netherlands Roman Tarlavski, Part­ner Mar­cel­lina Rietvelt, Associate, both Corporate / M&A Martijn van der Bie, Partner Gieneke van Nierop, Counsel, both Corporate / Notaries CMS Norway Nicolas Jorn Brunet, Partner Tuva Svare, Associate, both Corporate / M&A Henrik Nordling, Partner, Antitrust, Competition & TradePress Con­tact presse@cms-hs. com